Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMTJAMA Network Open · 2026-09-29A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.ACS chemical neuroscience · 2026-08-05Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.British journal of pharmacology · 2026-07-01Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot StudyClinicalTrials.gov · 2026-05-06A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-ControlClinicalTrials.gov · 2026-05-04Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Journal of medical Internet research · 2026-04-27A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).Journal of psychoactive drugs · 2026-03-16Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04The Rise of Psilocybin Use in the United States: A Multisource Observational Study.Annals of internal medicine · 2025-07-01Polysubstance Use Profiles Among the General Adult Population, United States, 2022.American journal of public health · 2025-05-01Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.The Journal of pharmacology and experimental therapeutics · 2025-01-01Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.Expert opinion on emerging drugs · 2024-09-01Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelicsbioRxiv · 2024-06-16Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.British journal of clinical pharmacology · 2023-09-01Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.CNS spectrums · 2023-08-01“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbanceResearch Square · 2023-07-27Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.Cureus · 2022-11-01Review of potential psychedelic treatments for PTSD.Journal of the neurological sciences · 2022-08-15How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.Psychopharmacology · 2022-06-01Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.Trends in pharmacological sciences · 2021-11-01Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia NervosaOBM Neurobiology · 2021-06-24Psilocybin: the magic medicine for depression?BJPsych open · 2021-06-18Psilocybin: the magic medicine for depression?BJPsych Open · 2021-06-01Hallucinogens and Their Therapeutic Use: A Literature Review.Journal of psychiatric practice · 2019-09-01HallucinogensPediatrics in Review · 2006-08-01Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.Brain research · 1975-08-22Induction and extinction of psilocybin induced transformations of visual space.Pharmakopsychiatrie, Neuro-Psychopharmakologie · 1973-09-01Psychophysics of psilocybin and 9 -tetrahydrocannabinol.Agents and actions · 1973-05-01Psilocybin-induced contraction of nearby visual space.Agents and actions · 1970-08-01Psilocybin-Induced Transformations of Visual SpacePharmacopsychiatry · 1970-07-01Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial DistortionPharmacopsychiatry · 1969-11-01Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.Experientia · 1969-02-15Effects of excitatory and tranquilizing drugs on visual perception. Spatial distortion thresholds.Experientia · 1969-01-30